News Industry News CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI October 17, 2020
News Conference News TCT 2020 Stent Polymer Face-off Calls Bioresorbable Coatings Into Question Shelley Wood October 17, 2020
News Opinion Editor's Corner TCT 2020 TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More Shelley Wood October 09, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Industry News CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial June 01, 2020